MedAlliance

MedAlliance

Developing ground-breaking technology for the treatment of coronary and peripheral artery disease.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
*

$200m

Valuation: $325m

Acquisition
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Investments by MedAlliance

Edit
MDK Medical
ACQUISITION by MedAlliance Feb 2022